NCT05643872: A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita
- State
- Under way
- Phase
- Phase 3
- People
- 45 planned
- Started
- 15 Nov 2022
- Primary completion
- Oct 2023
- Arms
- PTX-022
- Results
- None posted
- 15 Nov 2022: Trial started
- 9 Dec 2022: Trial registered